A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)

PHASE3RecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 27, 2024

Primary Completion Date

August 31, 2027

Study Completion Date

December 31, 2030

Conditions
Multiple Myeloma
Interventions
DRUG

Equecabtagene Autoleucel Injection

dosage form: injection, dosage: 1.0×10\^6 CAR-T/kg, frequency: single dose.

DRUG

Daratumumab

"dosage form: Injection dose level:16mg/kg frequency: 28days/cycle for DPd regimen~* Cycle1-2:D1, D8, D15, D22;~* Cycle3-6:D1, D15;~* above Cycle7:D1"

DRUG

Pomalidomide

dosage form:capsule. doseage form: capsule. dose level: 4mg/d. frequency: every cycle: D1-D21 for DPd regimen, D1-D14 for PVd regimen.

DRUG

Bortezomib

dosage form: subcutaneous injection. dose level: 1.3mg/m2. frequency: 21days/cycle for PVd regimen cycle 1-8: D1,D4, D8, D11; above cycle 9: D1, D8.

DRUG

Dexamethasone

dosage form: oral or intravenus injection. dose level:20mg/d. frequency: for DPd: every cycle, D1, D2, D8, D9, D15, D16, D22, D23; for PVd: Cycle1-8:D1, D2, D4, D5, D8, D9, D11, D12; above Cycle 9: D1, D2, D8, D9.

Trial Locations (28)

Unknown

RECRUITING

Beijing Chao-Yang Hospital, Capital Medical University, Beijing

RECRUITING

Beijing GoBoard Boren Hospital, Beijing

RECRUITING

Fu Xing Hospital, Capital Medical University, Beijing

RECRUITING

Peking Union Medical College Hospital, Beijing

RECRUITING

Peking University First Hospital, Beijing

RECRUITING

Peking University Third Hospital, Beijing

RECRUITING

People's Hospital of Peking University, Beijing

RECRUITING

The first hospital of Jilin University, Changchun

RECRUITING

West China School of Medicine, West China Hospital of Sichuan University, Chengdu

RECRUITING

Xinqiao Hospital of AMU, Chongqing

RECRUITING

Nanfang Hospital, Southern Medical University, Guangzhou

RECRUITING

Sun Yat-sen University Cancer Centre, Guangzhou

RECRUITING

Zhujiang Hospital of Southern Medical University Guangdong, Guangzhou

RECRUITING

The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou

RECRUITING

The Second Affiliated Hospital,Zhejiang University School of Medicine, Hangzhou

RECRUITING

Qilu Hospital of Shangdong University, Jinan

RECRUITING

The First Affiliated Hospital of Nanchang University, Nanchang

RECRUITING

Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing

RECRUITING

Jiangsu Province Hospital, Nanjing

RECRUITING

The Affiliated People's Hospital of Ningbo University, Ningbo

RECRUITING

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

RECRUITING

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjing

RECRUITING

Tianjin Medical University General Hospital, Tianjing

RECRUITING

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

RECRUITING

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

RECRUITING

Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan

RECRUITING

Henan Cancer Hospital Affilated Cancer Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
lead

Nanjing IASO Biotechnology Co., Ltd.

INDUSTRY